Theo J. M. Ingenhoven
Research Subjects
Theo J. M. Ingenhoven has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Hugo J. Duivenvoorden
2 shared publicationsAnne Lindenborn
1 shared publicationJan Passchier
1 shared publicationJanneke Brogtrop
1 shared publicationRobert E. Abraham
Developmental Profile Foundation, Amsterdam, The Netherlands
1 shared publicationWim van Den Brink
1 shared publication
Latest Publications
- 22 April 2015
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 76 (4) , e522-e523
Pharmacotherapy for Borderline Patients: Business as Usual or by Default?
In their analysis of a representative sample from the Prescribing Observatory for Mental Health in the UK health services, Paton et al found that 92% of patients with borderline personality disorder (BPD) received prescriptions for psychotropic medications. Although international guidelines recommend pharmacotherapy for comorbid psychiatric disorders whenever necessary, 82% of the UK BPD patients without such comorbid conditions nevertheless received pharmacotherapy "by default," mostly off-label polypharmacy without adequate psychiatric controls for effectiveness and tolerability. Business as usual? Bad care? International practice guidelines for the treatment of BPD all recommend evidence-based psychological treatment whenever possible (especially manualized psychotherapy like dialectical behavior therapy, schema-focused therapy, mentalization-based treatment, transference-focused psychotherapy) as the first-choice treatment.
- 22 April 2015
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 76 (4) , e522-e523
Pharmacotherapy for Borderline Patients: Business as Usual or by Default?
In their analysis of a representative sample from the Prescribing Observatory for Mental Health in the UK health services, Paton et al found that 92% of patients with borderline personality disorder (BPD) received prescriptions for psychotropic medications. Although international guidelines recommend pharmacotherapy for comorbid psychiatric disorders whenever necessary, 82% of the UK BPD patients without such comorbid conditions nevertheless received pharmacotherapy "by default," mostly off-label polypharmacy without adequate psychiatric controls for effectiveness and tolerability. Business as usual? Bad care? International practice guidelines for the treatment of BPD all recommend evidence-based psychological treatment whenever possible (especially manualized psychotherapy like dialectical behavior therapy, schema-focused therapy, mentalization-based treatment, transference-focused psychotherapy) as the first-choice treatment.
- 1 August 2012
- Published by Springer Nature in Psychopraktijk
- Vol. 4 (4) , 25-26
Persoonlijkheidsstoornissen in de DSM-5
- 1 August 2012
- Published by Springer Nature in Psychopraktijk
- Vol. 4 (4) , 25-26
Persoonlijkheidsstoornissen in de DSM-5
- 1 August 2011
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 31 (4) , 489-496
Differential Effectiveness of Antipsychotics in Borderline Personality Disorder
In clinical practice, antipsychotic drugs are widely used in borderline personality disorder (BPD). To evaluate current pharmacological treatment algorithms and guidelines for BPD, the authors reviewed and meta-analyzed studies on the effectiveness of antipsychotics on specific symptom domains in BPD. The literature was searched for placebo-controlled, randomized clinical trials (PC-RCTs) on the effectiveness of antipsychotics regarding cognitive perceptual symptoms, impulsive behavioral dyscontrol, and affective dysregulation (with subdomains depressed mood, anxiety, anger, and mood lability) in BPD. Studies whose primary emphasis was on the treatment of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition schizotypal personality disorder or Axis I disorders were excluded. Meta-analyses were conducted using 11 retrieved studies including 1152 borderline patients. Antipsychotics have a significant effect on cognitive perceptual symptoms (9 PC-RCTs; standardized mean difference [SMD], 0.23) and mood lability (5 PC-RCTs; SMD, 0.20) as well as on global functioning (8 PC-RCTs; SMD, 0.25), but these effects have to be qualified as small. Antipsychotics have a more pronounced effect on anger (9 PC-RCTs; SMD, 0.39). Antipsychotics did not have a significant effect on impulsive behavioral dyscontrol, depressed mood, and anxiety in BPD. Drug therapy tailored to well-defined symptom domains can have beneficial effects in BPD. At short term, antipsychotics can have significant effects on cognitive-perceptual symptoms, anger, and mood lability, but the wide and long-term use of antipsychotics in these patients remains controversial. The findings from this study raise questions on current pharmacological algorithms and clinical guidelines.
- 1 August 2011
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 31 (4) , 489-496
Differential Effectiveness of Antipsychotics in Borderline Personality Disorder
In clinical practice, antipsychotic drugs are widely used in borderline personality disorder (BPD). To evaluate current pharmacological treatment algorithms and guidelines for BPD, the authors reviewed and meta-analyzed studies on the effectiveness of antipsychotics on specific symptom domains in BPD. The literature was searched for placebo-controlled, randomized clinical trials (PC-RCTs) on the effectiveness of antipsychotics regarding cognitive perceptual symptoms, impulsive behavioral dyscontrol, and affective dysregulation (with subdomains depressed mood, anxiety, anger, and mood lability) in BPD. Studies whose primary emphasis was on the treatment of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition schizotypal personality disorder or Axis I disorders were excluded. Meta-analyses were conducted using 11 retrieved studies including 1152 borderline patients. Antipsychotics have a significant effect on cognitive perceptual symptoms (9 PC-RCTs; standardized mean difference [SMD], 0.23) and mood lability (5 PC-RCTs; SMD, 0.20) as well as on global functioning (8 PC-RCTs; SMD, 0.25), but these effects have to be qualified as small. Antipsychotics have a more pronounced effect on anger (9 PC-RCTs; SMD, 0.39). Antipsychotics did not have a significant effect on impulsive behavioral dyscontrol, depressed mood, and anxiety in BPD. Drug therapy tailored to well-defined symptom domains can have beneficial effects in BPD. At short term, antipsychotics can have significant effects on cognitive-perceptual symptoms, anger, and mood lability, but the wide and long-term use of antipsychotics in these patients remains controversial. The findings from this study raise questions on current pharmacological algorithms and clinical guidelines.
- 1 July 2010
- Published by American Psychiatric Association Publishing in American Journal of Psychotherapy
- Vol. 64 (3) , 215-238
Making Diagnosis More Meaningful. The Developmental Profile: a Psychodynamic Assessment of Personality
The Developmental Profile (DP) offers a psychodynamic description of the degree to which an individual has developed adaptive functioning appropriate to his or her age, and the extent to which dail...
- 1 July 2010
- Published by American Psychiatric Association Publishing in American Journal of Psychotherapy
- Vol. 64 (3) , 215-238
Making Diagnosis More Meaningful. The Developmental Profile: a Psychodynamic Assessment of Personality
The Developmental Profile (DP) offers a psychodynamic description of the degree to which an individual has developed adaptive functioning appropriate to his or her age, and the extent to which dail...
- 1 October 2009
- Published by Guilford Publications in Journal of Personality Disorders
- Vol. 23 (5) , 528-534
Brief Communications: Interrater Reliability for Kernberg's Structural Interview for Assessing Personality Organization
Interrater reliability is considered a precondition for the validity of theoretical models and their corresponding diagnostic instruments. Studies have documented good interrater reliability for structured interviews measuring personality characteristics on a descriptive-phenomenological level but there is little research on reliability of assessment procedures on a structural level. The current study investigated the interrater reliability of the structural interview (SI) designed to assess neurotic, borderline, and psychotic personality organization according to Kernberg. Videotaped SIs of 69 psychiatric patients were randomly and independently rated by two out of three trained psychologists. Agreement between rater pairs was expressed as square weighted kappa (K(sw), 95% CI). Results indicate satisfactory interrater reliability with respect to Kernberg's tripartite classification (K(sw) = 0.42, 95% CI 0.07 to 0.77). Subdivision of the borderline category or introduction of intermediate subcategories to the tripartite system did not significantly affect reliability (K(sw) = 0.55, 95% CI 0.30 to 0.80; K(sw) = 0.59, 95% CI 0.34 to 0.84, respectively). The conclusion is that trained clinicians can reliably assess structural personality organization using the SI. Refining the nosological system adding subcategories did not reduce reliability.
- 1 October 2009
- Published by Guilford Publications in Journal of Personality Disorders
- Vol. 23 (5) , 528-534
Brief Communications: Interrater Reliability for Kernberg's Structural Interview for Assessing Personality Organization
Interrater reliability is considered a precondition for the validity of theoretical models and their corresponding diagnostic instruments. Studies have documented good interrater reliability for structured interviews measuring personality characteristics on a descriptive-phenomenological level but there is little research on reliability of assessment procedures on a structural level. The current study investigated the interrater reliability of the structural interview (SI) designed to assess neurotic, borderline, and psychotic personality organization according to Kernberg. Videotaped SIs of 69 psychiatric patients were randomly and independently rated by two out of three trained psychologists. Agreement between rater pairs was expressed as square weighted kappa (K(sw), 95% CI). Results indicate satisfactory interrater reliability with respect to Kernberg's tripartite classification (K(sw) = 0.42, 95% CI 0.07 to 0.77). Subdivision of the borderline category or introduction of intermediate subcategories to the tripartite system did not significantly affect reliability (K(sw) = 0.55, 95% CI 0.30 to 0.80; K(sw) = 0.59, 95% CI 0.34 to 0.84, respectively). The conclusion is that trained clinicians can reliably assess structural personality organization using the SI. Refining the nosological system adding subcategories did not reduce reliability.